Literature DB >> 32440718

ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS).

Tawakalitu O Oseni1, Manisha Bahl2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32440718     DOI： 10.1245/s10434-020-08637-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS).

Authors:  S Soumian; E T Verghese; M Booth; N Sharma; S Chaudhri; S Bradley; S Umranikar; R A Millican-Slater; A M Hanby; A Francis
Journal:  Eur J Surg Oncol       Date:  2013-10-09       Impact factor: 4.424

2.  Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Authors:  Melissa Pilewskie; Michelle Stempel; Hope Rosenfeld; Anne Eaton; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-05-12       Impact factor: 5.344

3.  Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.

Authors:  Lars J Grimm; Marc D Ryser; Ann H Partridge; Alastair M Thompson; Jeremy S Thomas; Jelle Wesseling; E Shelley Hwang
Journal:  Ann Surg Oncol       Date:  2017-08-09       Impact factor: 5.344

Review 4.  Estimating the magnitude of clinical benefit of local therapy in patients with DCIS.

Authors:  E Shelley Hwang; Veronika Malek
Journal:  Breast       Date:  2019-11       Impact factor: 4.380
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.